← Back to Search

Radiation Therapy

Single Pre-Operative Radiation Therapy for Breast Cancer (SPORT Trial)

Phase 1
Waitlist Available
Research Sponsored by Maisonneuve-Rosemont Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

The purpose of this study is to determine if partial breast irradiation administered in a single preoperative fraction is tolerable.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute toxicity
Secondary outcome measures
Chronic toxicity
Cosmetic outcome
Other outcome measures
Ipsilateral breast cancer recurrence

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single Pre-Operative Radiation TherapyExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Single Pre-Operative Radiation Therapy
2012
Completed Phase 1
~10

Find a Location

Who is running the clinical trial?

Maisonneuve-Rosemont HospitalLead Sponsor
99 Previous Clinical Trials
36,313 Total Patients Enrolled
1 Trials studying Breast Cancer
80 Patients Enrolled for Breast Cancer
Michael Yassa, MDStudy ChairMaisonneuve-Rosemon Hospital
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top